Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tiny zaps for fibro pain: new study tests microcurrent therapy

NCT ID NCT04949100

Symptom relief Sponsor: Paul Crawford Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 2 times

Summary

This study tests whether microcurrent therapy—a very mild electrical stimulation—can reduce pain and improve daily life for people with fibromyalgia. About 50 adults will use a device at home alongside their usual pain care. The goal is to see if this simple, self-administered treatment can be a helpful addition to managing fibromyalgia symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Oct 2021

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 74 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

\*\*Patients must be able to get care at Nellis Air Force Base (a military installation) in order to participate in this study\*\* Inclusion Criteria: * Male and female Active Duty or DoD beneficiary aged 18-74 years old. * Meets diagnostic criteria of fibromyalgia as defined by the American College of Rheumatology 1990 Criteria 1,18 to be consistent with prior research. * Symptom duration of at least 3 months * Tender points: having \>10/18 tender points * Pain-affected areas includes all quadrants of the body * Other causes excluded clinically * History of a neck injury sometime in their life Exclusion Criteria: * Peripheral neuropathy * Pregnancy * History of: * Brain/spine surgery * Nerve entrapment surgery * Severe bony deformities or contracture * Hypersensitive reaction to the surface electrode * Severe psychological disorders * Current alcohol or drug abuse. (caveat: medical marijuana is permitted) * Active infections * Active cancer * Cardiac arrhythmias (If yes, please list \_\_\_\_\_\_\_\_\_\_\_\_\_) * Received an organ transplant * Pacemakers and electrically implanted electronic devices * Subjects scheduled for surgery will not be eligible to participate in thisstudy until 6 weeks post-surgery.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fibromyalgia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Pain fibromyalgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fibromyalgia

Contacts and locations

Locations

  • Mike O'Callaghan Military Medical Center

    Nellis Air Force Base, Nevada, 89191, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.